SNTA Insider Trading Activity and SEC Form 4 Filings
SNTA insider trading summary
No open-market insider purchases or sales of Synta Pharmaceuticals Corp (SNTA) have been reported on SEC Form 4 in the past 12 months.
Latest SNTA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 14, 2015 | Keith R Gollust | Director | Sell | $97K (300,000 @ $0.32) |
| Dec 11, 2015 | Keith R Gollust | Director | Sell | $111K (300,000 @ $0.37) |
| Dec 9, 2015 | Keith R Gollust | Director | Sell | $55K (145,892 @ $0.38) |
| Dec 8, 2015 | Bruce Kovner | Director | Sell | $184K (496,015 @ $0.37) |
| Dec 8, 2015 | Keith R Gollust | Director | Sell | $114K (300,000 @ $0.38) |
| Dec 8, 2015 | Bruce Kovner | Director | Sell | $323K (873,624 @ $0.37) |
| Dec 7, 2015 | Keith R Gollust | Director | Sell | $116K (300,000 @ $0.39) |
| Dec 7, 2015 | Bruce Kovner | Director | Sell | $26 (64 @ $0.41) |
| Dec 7, 2015 | Bruce Kovner | Director | Sell | $15 (36 @ $0.41) |
| Dec 4, 2015 | Bruce Kovner | Director | Sell | $40K (97,978 @ $0.41) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.